A detailed history of Allworth Financial LP transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Allworth Financial LP holds 373 shares of BCRX stock, worth $2,901. This represents 0.0% of its overall portfolio holdings.

Number of Shares
373
Previous 373 -0.0%
Holding current value
$2,901
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$4.13 - $6.79 $3,225 - $5,302
-781 Reduced 67.68%
373 $2,000
Q1 2024

Apr 25, 2024

BUY
$4.89 - $7.65 $2,009 - $3,144
411 Added 55.32%
1,154 $5,000
Q4 2023

Jan 24, 2024

BUY
$4.98 - $6.77 $1,215 - $1,651
244 Added 48.9%
743 $4,000
Q3 2023

Oct 31, 2023

BUY
$6.71 - $7.92 $1,476 - $1,742
220 Added 78.85%
499 $3,000
Q2 2023

Jul 18, 2023

BUY
$6.96 - $8.81 $842 - $1,066
121 Added 76.58%
279 $1,000
Q1 2023

Apr 18, 2023

BUY
$7.94 - $11.84 $301 - $449
38 Added 31.67%
158 $1,000
Q3 2022

Oct 18, 2022

BUY
$10.79 - $14.81 $1,165 - $1,599
108 Added 900.0%
120 $2,000
Q2 2022

Jul 13, 2022

BUY
$7.89 - $17.88 $94 - $214
12 New
12 $0
Q2 2018

Aug 08, 2018

SELL
$4.6 - $6.52 $2,300 - $3,260
-500 Closed
0 $0
Q3 2017

Oct 12, 2017

BUY
$4.1 - $5.97 $2,050 - $2,985
500
500 $3,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.45B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.